Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Premedication for IANB in Pulpitis
NCT07146997Phase 3Completed
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen, serrapeptase in irreversible pulpitis. Started Nov 2023; status: completed.
02
Drugs
ibuprofenserrapeptase
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07146997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07146997.